Karius, Inc.
Karius, Inc.
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Metagenomic Sequencing Across the Infectious Disease Risk and Care Continuum | Disease Attributes, Hemic and Lymphatic Diseases, Infections, Neoplasms by Site, Opportunistic Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, hematologic disorder, hematopoietic and lymphoid system neoplasm, infectious disease, neoplasm | Not yet recruiting | Not stated | 2026-09-17 | NCT07825714 | |
| Next Generation Pathogen Sequencing for Prediction of Adverse Events | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome, neoplasm | Active, not recruiting | Not stated | 2026-07-20 | NCT03226158 | |
| Microbial Cell-free Metagenomic Sequencing for Suspected Infections in Adult Immunocompromised Outpatients | Bacterial Infections and Mycoses, Infections, bacterial infectious disease, fungal infectious disease, parasitic infectious disease, viral infectious disease | Recruiting | Not applicable | 2026-01-30 | NCT07110636 |